| |
| |
|
| Insider
Information: |
Carey Robert |
| Relationship: |
Director |
| City: |
Deerfield |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
3,051,937 |
|
|
Indirect Shares
|
249,091 |
|
|
| Direct
Value |
$515,086 |
|
|
|
Indirect Value
|
$7,049,275 |
|
|
| Total
Shares |
3,301,028 |
|
|
| Total
Value |
$7,564,361 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Horizon Pharma, Inc. |
HZNP |
EVP, Chief Business Of... |
2019-03-23 |
17,267 |
2019-03-23 |
249,091 |
Premium* |
|
|
Argos Therapeutics Inc |
ARGS |
Director |
2016-12-31 |
8,206 |
2016-03-31 |
0 |
Premium* |
|
|
Sangamo Biosciences Inc |
SGMO |
Director |
2023-06-01 |
49,600 |
2018-06-11 |
0 |
Premium* |
|
|
Beyond Air Ord Shs |
XAIR |
Director |
2024-03-20 |
2,976,864 |
2019-06-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
66 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| XAIR |
Beyond Air Ord Shs |
Director |
– • – |
2021-11-19 |
4 |
B |
$14.10 |
$169,200 |
D/D |
12,000 |
493,418 |
2.39 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP & Chief Business Officer |
• – – |
2015-03-05 |
4 |
D |
$20.84 |
$202,898 |
D/D |
(9,736) |
23,245 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, Chief Business Officer |
• – – |
2017-03-23 |
4 |
D |
$14.56 |
$206,272 |
D/D |
(14,167) |
34,190 |
0 |
- |
|
| XAIR |
Beyond Air Ord Shs |
Director |
– • – |
2023-08-21 |
4 |
B |
$2.76 |
$207,453 |
D/D |
75,050 |
975,160 |
2.39 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, Chief Business Officer |
• – – |
2018-03-05 |
4 |
D |
$15.83 |
$219,024 |
D/D |
(13,836) |
17,189 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, Chief Business Officer |
• – – |
2016-03-23 |
4 |
D |
$16.32 |
$231,205 |
D/D |
(14,167) |
38,242 |
0 |
- |
|
| XAIR |
Beyond Air Ord Shs |
Director |
– • – |
2020-08-14 |
4 |
B |
$5.50 |
$337,500 |
D/D |
60,000 |
89,418 |
2.39 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, Chief Business Officer |
• – – |
2019-03-23 |
4 |
D |
$26.84 |
$368,594 |
D/D |
(13,733) |
17,267 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, Chief Business Officer |
• – – |
2017-03-01 |
4 |
S |
$16.00 |
$480,000 |
I/I |
(30,000) |
95,408 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, Chief Business Officer |
• – – |
2019-01-05 |
4 |
D |
$20.39 |
$599,853 |
D/D |
(29,419) |
36,276 |
0 |
- |
|
| XAIR |
Beyond Air Ord Shs |
Director |
– • – |
2023-08-28 |
4 |
B |
$2.70 |
$673,750 |
D/D |
250,000 |
1,225,160 |
2.39 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, Chief Business Officer |
• – – |
2019-02-20 |
4 |
D |
$21.54 |
$690,659 |
D/D |
(32,064) |
40,311 |
0 |
- |
|
| XAIR |
Beyond Air Ord Shs |
Director |
– • – |
2024-03-20 |
4 |
A |
$1.66 |
$1,000,001 |
D/D |
602,410 |
2,976,864 |
0 |
- |
|
| XAIR |
Beyond Air Ord Shs |
Director |
– • – |
2022-06-30 |
4 |
B |
$6.45 |
$1,128,295 |
D/D |
175,000 |
742,323 |
2.39 |
- |
|
| XAIR |
Beyond Air Ord Shs |
Director |
– • – |
2021-06-17 |
4 |
B |
$5.36 |
$1,876,000 |
D/D |
350,000 |
481,418 |
2.39 |
- |
|
| XAIR |
Beyond Air Ord Shs |
Director |
– • – |
2023-12-18 |
4 |
B |
$1.64 |
$1,962,000 |
D/D |
1,200,000 |
2,374,454 |
2.39 |
- |
|
66 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
